All News

Although the healthcare bills have many fundamental similarities, the Senate’s Better Care Reconciliation Act differs from the House’s American Health Care Act (AHCA) in ways that extend beyond the name change.

The top managed care stories this week included proposed rule changes to the implementation of the Medicare Access and CHIP Reauthorization Act; a study found Medicaid expansion increased emergency department utilization; and a diabetes drug received a new cardiovascular indication.

The FDA has approved the use of Janssen Biotech, Inc’s immunotherapy Darzalex in combination with pomalidomide and dexamethasone. Darzalex is used to treat multiple myeloma patients who have previously received at least 2 therapies with lenalidomide and a proteasome inhibitor.

Researchers investigating the risks of breast, ovarian, and contralateral breast cancer for mutation carriers found that family history and mutation position are important for determining cancer risk estimates, according to a study published in JAMA.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Yousuf Zafar, MD, will advise The Samfund on research and evaluation of data to enhance its ability to combat financial aftereffects of cancer treatment.

The update follows an earlier report from Express Scripts on the nation's crisis, which revealed that women are using more opioids than men.

The FDA has approved Baxdela, a drug intended to treat adults with acute bacterial skin and skin structure infections caused by susceptible bacteria. Baxdela is also effective in treating MRSA and against other gram-positive or gram-negative pathogens.

The review of 8 studies on gastrointestinal injury related to exercise found that distress set in after the 2-hour mark, which is significant because no one has ever completed the 26.2-mile marathon in that time.

Republican leaders in the Senate unveiled a long-awaited healthcare reform bill, called the Better Care Reconciliation Act of 2017, that will roll back the Affordable Care Act’s taxes and Medicaid expansion, although at a slower timeline than included in the House of Representatives’ American Health Care Act, which was passed on May 4 by a vote of 217-213.

The study highlights the importance of Medicare's plan to launch the Diabetes Prevention Program in early 2018.

A new study in the New England Journal of Medicine has found that a combination of tumor mutation burden and expression of the programmed death ligand-1 (PD-L1) can predict patient response to nivolumab in non—small-cell lung cancer (NSCLC).

At the 8th Annual Oncology Market Access & Pricing USA 2017 meeting hosted by eyeforpharma, Sriram Shankar, senior consultant, INC Strategy Consulting, shared his thoughts on the implications of value frameworks for payer strategy.

In response to trepidation from clinicians, CMS has announced a proposal to alter the rules of the Quality Payment Program established by the Medicare Access and CHIP Reauthorization Act (MACRA). The changes will exempt thousands of physicians from quality reporting requirements and allow small practices to form “virtual groups” with one another.

Liraglutide, a GLP-1 receptor agonist sold as Victoza, becomes the second diabetes therapy to receive the cardiovascular indication.

When undergoing therapy for cancer, patients must be aware of the risks of adverse interactions between the therapy and any other drugs or herbal supplements they take, a new study cautions.

According to a research study published in the journal Cancer, Asian women are less likely than non-Hispanic white women to receive timely follow-up after an abnormal screening mammogram.

With more women dying annually from chronic obstructive pulmonary disease (COPD) than men since 2000, researchers have examined trends in COPD hospitalization and in-hospital mortality, evaluating for differences by sex and race. They presented their research at the American Thoracic Society 2017 International Conference.

A new report from the United States Government Accountability Office is calling for pharmacy systems to better serve veterans through additional capabilities for viewing, exchanging, and using data.

The Duke Center for Health Data Science was in the planning stages before Robert Califf, MD, departed for a stint as FDA commissioner.

The Supreme Court of the United States has determined that a group of nonresident plaintiffs may not sue Bristol-Myers Squibb (BMS) in California state court, as neither these patients nor the pharmaceutical company reside in that state. The ruling could have important implications for lawsuits seeking compensation for alleged harms.

A collaborative study among scientists working across 3 continents has found a strong association between circulating free DNA in patients being treated with olaparib (Lynparza) for prostate cancer and disease outcome.

The new law includes requirements that drugmakers reveal discounts for pharmacy benefit managers and prevents gag rules on pharmacists who want to suggest cheaper alternatives.

As the opioid epidemic continues across America, medication-assisted therapies, like buprenorphine or naltrexone, have been highlighted as an important tool. However, a new study indicates that the number of young people with opioid use disorder who actually receive these medications remains low, although it has increased since 2001.

Young adult cancer survivors face an uncertain path to parenthood-here is one story.

Experts hoped that Medicaid expansion would direct the previously uninsured into primary care and reduce reliance on the emergency department. What happened is more complicated.